Lupin launches Glucagon for Injection USP, 1 mg/Vial in US Market
Lupin has launched its Glucagon for Injection USP, 1mg/vial emergency kit in the US, a bioequivalent to Eli Lilly’s product, for treating severe hypoglycemia and aiding certain radiologic procedures.
Product Launch | 12/08/2025 | By Mrinmoy Dey
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy